https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15838 Wed 11 Apr 2018 16:43:01 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10436 Wed 11 Apr 2018 15:28:20 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18572 Wed 11 Apr 2018 13:18:20 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16787 Wed 11 Apr 2018 13:10:03 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24289 Wed 11 Apr 2018 12:16:30 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9453 Wed 11 Apr 2018 10:12:24 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16843 Tue 24 Aug 2021 14:34:49 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13833 Tue 24 Aug 2021 14:29:46 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8091 Sat 24 Mar 2018 08:34:27 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31395 N = 754) were randomised to receive either usual care (n = 375) or an intervention comprising a brief mot ivational interview and self-help material while in hospital, followed by a 4-month pharmacological and psychosocial intervention (n = 379) upon discharge. Primary outcomes assessed at 6 and 12 months post-discharge were 7-day point prevalence and 1-month prolonged smoking abstinence. A number of secondary smoking-related outcomes were also assessed. Subgroup analyses were conducted based on psychiatric diagnosis, baseline readiness to quit and nicotine dependence. Results: Seven-day point prevalence abstinence was higher for intervention participants (15.8%) than controls (9.3%) at 6 months post-discharge (odds ratio = 1.07, p = 0.04), but not at 12 months (13.4% and 10.0%, respectively; odds ratio = 1.03, p = 0.25). Significant intervention effects were not found on measures of prolonged abstinence at either 6 or 12 months post-discharge. Differential intervention effects for the primary outcomes were not detected for any subgroups. At both 6 and 12 months post-discharge, intervention group participants were significantly more likely to smoke fewer cigarettes per day, have reduced cigarette consumption by 3/450% and to have made at least one quit attempt, relative to controls. Conclusions: Universal smoking cessation treatment initiated in inpatient psychiatry and continued post-discharge was efficacious in increasing 7-day point prevalence smoking cessation rates and related quitting behaviours at 6 months post-discharge, with sustained effects on quitting behaviour at 12 months. Further research is required to identify strategies for achieving longer term smoking cessation.]]> Fri 03 Dec 2021 10:34:17 AEDT ]]>